首页 > 最新文献

中国疫苗和免疫最新文献

英文 中文
[Norovrius genotype I.8 being detected from sporadic cases of acute gastroenteritis in Nanning municipal]. [南宁市散在急性胃肠炎病例中检出诺如病毒I.8基因型]。
Pub Date : 2010-06-01
Li-li Deng, Wei Liu, Dong-mei Tan

Objective: To study the genic characteristic of Norovrius genotype I.8 from sporadic gastroenteritis of a hospital in Nanning Municipal.

Methods: Specimens of diarrhea patients from a hospital in Nanning Municipal between January 2007 and December 2008 were collected and detected for Noroviral genogroup Iribonucleic acid (RNA) by real-time reverse transcription-polymerase chain reaction(real-time RT-PCR). All positive specimens were subjected for sequencing analysis and constructed phylogenetic tree.

Results: Norovirus genogroup I RNA were detected in 3 of 696 stool specimens. The homology between one of the four strains (NN07230) and reference strain of G I.8 (WUG I/00/JP) was 94.5%; and the homology between the NN07230 strain and strains circulating during 2006-2007 in Japan and Korea ranged from 96.7% to 98.5%. And they formed one cluster in the phylogenetic tree.

Conclusion: The research showed that genotype I.8 infection exists in sporadic gastroenteritis in Nanning City.

目的:研究南宁市某医院散发性肠胃炎患者诺如病毒I.8基因型的基因特征。方法:收集2007年1月~ 2008年12月南宁市某医院腹泻患者标本,采用实时逆转录聚合酶链反应(real-time RT-PCR)检测诺如病毒基因群核糖核酸(RNA)。所有阳性标本进行测序分析,构建系统发育树。结果:696份粪便标本中3份检出诺如病毒I基因组RNA。其中1株(NN07230)与G I.8参考菌株(WUG I/00/JP)同源性为94.5%;NN07230株与2006-2007年日本、韩国流行株同源性为96.7% ~ 98.5%。它们在系统发育树上形成了一个集群。结论:南宁市散发性胃肠炎中存在I.8基因型感染。
{"title":"[Norovrius genotype I.8 being detected from sporadic cases of acute gastroenteritis in Nanning municipal].","authors":"Li-li Deng,&nbsp;Wei Liu,&nbsp;Dong-mei Tan","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To study the genic characteristic of Norovrius genotype I.8 from sporadic gastroenteritis of a hospital in Nanning Municipal.</p><p><strong>Methods: </strong>Specimens of diarrhea patients from a hospital in Nanning Municipal between January 2007 and December 2008 were collected and detected for Noroviral genogroup Iribonucleic acid (RNA) by real-time reverse transcription-polymerase chain reaction(real-time RT-PCR). All positive specimens were subjected for sequencing analysis and constructed phylogenetic tree.</p><p><strong>Results: </strong>Norovirus genogroup I RNA were detected in 3 of 696 stool specimens. The homology between one of the four strains (NN07230) and reference strain of G I.8 (WUG I/00/JP) was 94.5%; and the homology between the NN07230 strain and strains circulating during 2006-2007 in Japan and Korea ranged from 96.7% to 98.5%. And they formed one cluster in the phylogenetic tree.</p><p><strong>Conclusion: </strong>The research showed that genotype I.8 infection exists in sporadic gastroenteritis in Nanning City.</p>","PeriodicalId":56402,"journal":{"name":"中国疫苗和免疫","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29201100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Identification and genetic characteristics of five non-polio enteroviruses (NPEVs) multiplicated on L20B cell line]. [在L20B细胞系上增殖的5种非脊髓灰质炎肠病毒(npev)的鉴定和遗传特性]。
Pub Date : 2010-06-01
Dong-yan Wang, Yong Zhang, Shuang-li Zhu

Objective: To identify and describe the genetic characteristics of non-polio enteroviruses (NPEVs) which could multiplicated on L20B cell line, and discuss the impact to isolation rate of polioviruses.

Methods: 5 L20B positive isolates were collected from stool samples of patient with acute flaccid paralysis (AFP) and health children in Guangxi Zhuang autonomous region and Ningxia Hui autonomous region. These isolates were analysed using VP4 nucleotide sequencing method. The completed VP, coding regions were amplified and sequenced. Finally, phylogenetic tree were constructed base on completed VP1 coding regions sequences of these L20B positive isolates and those downloaded form GenBank database.

Results: The 5 NPEVs were all identified as coxsackieviruses group A (CVA). Among them, 1 was identified as CVA4, 1 was identified as CVA8 and 3 were identified as CVA10, and all of them belonged to human enterovirus species A (HEV-A). Nucleotide homology analysis and phylogenetic analysis base on completed VP1 coding regions sequences showed that all these 3 serotypes of NPEVs clustered independently, and they were all native circulated viruses in mainland China.

Conclusions: 5 NPEVs in this study belonged to HEV-A, covered 3 serotypes, CVA4, CVA8 and CVA10. Due to the high sensitivity of primarily inoculation of poliovirus onto L20B cell, the isolation rate of polioviruses could not be affected so much. Hand, foot, and mouth disease (HFMD) outbreaks in mainland China in recent years, and it was found that HEV-A is also pathogen of HFMD. Identification of these viruses have current significance to differential diagnosis of poliovirus infection and HFMD control and prevention.

目的:鉴定和描述可在L20B细胞株上增殖的非脊髓灰质炎肠病毒(npev)的遗传特征,并探讨其对脊髓灰质炎病毒分离率的影响。方法:从广西壮族自治区和宁夏回族自治区急性弛缓性麻痹(AFP)患者和健康儿童粪便标本中采集5株L20B阳性分离株。采用VP4核苷酸测序法对分离株进行分析。扩增完整的VP编码区并测序。最后,根据L20B阳性分离株完整的VP1编码区序列和从GenBank数据库下载的VP1编码区序列构建系统进化树。结果:5株npev均鉴定为柯萨奇病毒A组(CVA)。其中1例鉴定为CVA4, 1例鉴定为CVA8, 3例鉴定为CVA10,均属于人肠道病毒A种(HEV-A)。核苷酸同源性分析和基于完整VP1编码区序列的系统发育分析表明,3种血清型npev均独立聚集,均为中国大陆本地传播的病毒。结论:本研究5例npev属HEV-A型,涵盖CVA4、CVA8、CVA10 3种血清型。由于首次接种脊髓灰质炎病毒对L20B细胞的敏感性较高,对脊髓灰质炎病毒的分离率影响不大。近年来中国大陆手足口病(手足口病)暴发,发现HEV-A也是手足口病的病原。这些病毒的鉴定对脊髓灰质炎病毒感染的鉴别诊断和手足口病的控制和预防具有重要意义。
{"title":"[Identification and genetic characteristics of five non-polio enteroviruses (NPEVs) multiplicated on L20B cell line].","authors":"Dong-yan Wang,&nbsp;Yong Zhang,&nbsp;Shuang-li Zhu","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To identify and describe the genetic characteristics of non-polio enteroviruses (NPEVs) which could multiplicated on L20B cell line, and discuss the impact to isolation rate of polioviruses.</p><p><strong>Methods: </strong>5 L20B positive isolates were collected from stool samples of patient with acute flaccid paralysis (AFP) and health children in Guangxi Zhuang autonomous region and Ningxia Hui autonomous region. These isolates were analysed using VP4 nucleotide sequencing method. The completed VP, coding regions were amplified and sequenced. Finally, phylogenetic tree were constructed base on completed VP1 coding regions sequences of these L20B positive isolates and those downloaded form GenBank database.</p><p><strong>Results: </strong>The 5 NPEVs were all identified as coxsackieviruses group A (CVA). Among them, 1 was identified as CVA4, 1 was identified as CVA8 and 3 were identified as CVA10, and all of them belonged to human enterovirus species A (HEV-A). Nucleotide homology analysis and phylogenetic analysis base on completed VP1 coding regions sequences showed that all these 3 serotypes of NPEVs clustered independently, and they were all native circulated viruses in mainland China.</p><p><strong>Conclusions: </strong>5 NPEVs in this study belonged to HEV-A, covered 3 serotypes, CVA4, CVA8 and CVA10. Due to the high sensitivity of primarily inoculation of poliovirus onto L20B cell, the isolation rate of polioviruses could not be affected so much. Hand, foot, and mouth disease (HFMD) outbreaks in mainland China in recent years, and it was found that HEV-A is also pathogen of HFMD. Identification of these viruses have current significance to differential diagnosis of poliovirus infection and HFMD control and prevention.</p>","PeriodicalId":56402,"journal":{"name":"中国疫苗和免疫","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29201693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Effectiveness of 23-valent penumococcal polysaccharide and split-virus influenza vaccines to prevent respiratory diseases for elderly people]. [23价肺炎球菌多糖和分裂病毒流感疫苗预防老年人呼吸道疾病的有效性]。
Pub Date : 2010-06-01
Mao-ci Wang, Tai-ping Wang, Shao-ming Yang

Objective: To assess the effectiveness of 23-valent penumococcal polysaccharide vaccine (PenV23) and Split-Virus influenza vaccine (InfV-B) for preventing upper respiratory diseases in the aging population.

Methods: 151 people aged > or =60 years who inoculated the PenV23 and InfV-B vaccines at clinics during 2005 as trial group, and 188 people aged > or =65 years didn't administered as control guoup from some comminity. On base line survey, both guoups were followed up two years after vaccination about incidence, hospitalization rate, treatment and direct medical cost.

Results: The vaccine of PenV23 and InfV-B vaccination in upper respiratory tract infection was 60% [(odds ratio OR) = 0.35, 95% CI (0.153-0.794)] and the difference between the 2 groups was significant (P = 0.009). The people had recevied both vaccines, the mean duration of hospitalization in vaccinated vs unvaccinated control peple was 20.00 days: 24.19 days (t = 5.82, P < 0.001). Benefit-cost ratio was 4.03, and the net benefit was Yen 177994.86.

Conclusion: Incidence of influenza-like illness for the elderly people in the community decreased by administered PenV23 ahd InfV-B vaccine. This vaccines had high cost-benefits.

目的:评价23价肺炎球菌多糖疫苗(PenV23)和分裂病毒流感疫苗(InfV-B)预防老年人上呼吸道疾病的效果。方法:选取2005年在门诊接种过PenV23和乙型肝炎疫苗的年龄> 60岁的151人作为试验组,某社区年龄> 65岁的188人作为对照组。在基线调查的基础上,两组在接种疫苗后2年随访发病率、住院率、治疗情况和直接医疗费用。结果:PenV23疫苗与乙型流感病毒疫苗在上呼吸道感染中的感染率为60%[(优势比OR) = 0.35, 95% CI(0.153 ~ 0.794)],两组间差异有统计学意义(P = 0.009)。接种两种疫苗的人,接种疫苗和未接种疫苗的对照组的平均住院时间为20.00天:24.19天(t = 5.82, P < 0.001)。效益成本比为4.03,净效益为177994.86日元。结论:接种PenV23和乙型流感疫苗可降低社区老年人流感样疾病的发病率。这种疫苗具有很高的成本效益。
{"title":"[Effectiveness of 23-valent penumococcal polysaccharide and split-virus influenza vaccines to prevent respiratory diseases for elderly people].","authors":"Mao-ci Wang,&nbsp;Tai-ping Wang,&nbsp;Shao-ming Yang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To assess the effectiveness of 23-valent penumococcal polysaccharide vaccine (PenV23) and Split-Virus influenza vaccine (InfV-B) for preventing upper respiratory diseases in the aging population.</p><p><strong>Methods: </strong>151 people aged > or =60 years who inoculated the PenV23 and InfV-B vaccines at clinics during 2005 as trial group, and 188 people aged > or =65 years didn't administered as control guoup from some comminity. On base line survey, both guoups were followed up two years after vaccination about incidence, hospitalization rate, treatment and direct medical cost.</p><p><strong>Results: </strong>The vaccine of PenV23 and InfV-B vaccination in upper respiratory tract infection was 60% [(odds ratio OR) = 0.35, 95% CI (0.153-0.794)] and the difference between the 2 groups was significant (P = 0.009). The people had recevied both vaccines, the mean duration of hospitalization in vaccinated vs unvaccinated control peple was 20.00 days: 24.19 days (t = 5.82, P < 0.001). Benefit-cost ratio was 4.03, and the net benefit was Yen 177994.86.</p><p><strong>Conclusion: </strong>Incidence of influenza-like illness for the elderly people in the community decreased by administered PenV23 ahd InfV-B vaccine. This vaccines had high cost-benefits.</p>","PeriodicalId":56402,"journal":{"name":"中国疫苗和免疫","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29201097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis on disease burdern of Japanese encephalitis (JE) in Gansu province]. 甘肃省乙型脑炎(乙脑)疾病负担分析
Pub Date : 2010-06-01
Xu-xia Wang, Yi-xing Li, Zun-dong Yin

Objective: To evaluate the disease burden of Japanese Encephalitis (JE), and provide strategy for disease control and prevention.

Methods: Firstly, analysis the incidence, mortality and fatality rate of JE in Gansu province in 2006. Then the investigation was carried out for calculating all expenditure items of the patients, including medical cost of the hospitalization, medicines, the transport costs, and other non-medical direct cost.

Results: In 2006, among the 27 type A and B notifiable infectious diseases in Gansu Province, JE mortality rate was at the top 3, fatality rate was at first rank. The direct cost of JE disease was 6889 RMB per case. In 2006, the direct cost of JE cases was 1,116,000 RMB in Gansu Province.

Conclusion: JE had the high mortality, and fatality. The fatality in adult was higher than in children. JE patients had to pay high costs. JE disease burden should not be underestimated.

目的:评价乙型脑炎(乙脑)的疾病负担,为疾病控制和预防提供对策。方法:首先对2006年甘肃省乙脑发病、病死率和病死率进行分析。然后进行调查,计算患者的所有支出项目,包括住院医疗费用、药品费用、交通费和其他非医疗直接费用。结果:2006年甘肃省27种甲、乙类法定传染病中,乙脑致死率居前3位,致死率居首位。乙脑直接成本为6889元/例。2006年,甘肃省乙脑病例的直接成本为111.6万元。结论:乙脑病死率高,病死率高。成人致死率高于儿童。乙脑患者必须支付高昂的费用。不应低估乙脑疾病负担。
{"title":"[Analysis on disease burdern of Japanese encephalitis (JE) in Gansu province].","authors":"Xu-xia Wang,&nbsp;Yi-xing Li,&nbsp;Zun-dong Yin","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the disease burden of Japanese Encephalitis (JE), and provide strategy for disease control and prevention.</p><p><strong>Methods: </strong>Firstly, analysis the incidence, mortality and fatality rate of JE in Gansu province in 2006. Then the investigation was carried out for calculating all expenditure items of the patients, including medical cost of the hospitalization, medicines, the transport costs, and other non-medical direct cost.</p><p><strong>Results: </strong>In 2006, among the 27 type A and B notifiable infectious diseases in Gansu Province, JE mortality rate was at the top 3, fatality rate was at first rank. The direct cost of JE disease was 6889 RMB per case. In 2006, the direct cost of JE cases was 1,116,000 RMB in Gansu Province.</p><p><strong>Conclusion: </strong>JE had the high mortality, and fatality. The fatality in adult was higher than in children. JE patients had to pay high costs. JE disease burden should not be underestimated.</p>","PeriodicalId":56402,"journal":{"name":"中国疫苗和免疫","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29201101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research progress of influenza type A(H1N1) vaccine and monitoring adverse reaction]. [甲型H1N1流感疫苗研究进展及不良反应监测]。
Pub Date : 2010-06-01
Wei-wei Zhang, Liang Li, Feng-cai Zhu

A novel influenza type A(H1N1) virus was identified as a significant cause of acute respiratory illnesses, which spread rapidly to many countries around the world in 2009. The most effective method to prevent the outbreak of influenza type A (H1N1) was performed through large-scale immunization. Research progress and adverse reaction monitoring on influenza type A (H1N1) vaccines were reviewed.

一种新型甲型流感(H1N1)病毒被确定为急性呼吸道疾病的一个重要病因,该疾病在2009年迅速传播到世界许多国家。预防甲型H1N1流感爆发的最有效方法是大规模免疫接种。综述了甲型H1N1流感疫苗的研究进展及不良反应监测。
{"title":"[Research progress of influenza type A(H1N1) vaccine and monitoring adverse reaction].","authors":"Wei-wei Zhang,&nbsp;Liang Li,&nbsp;Feng-cai Zhu","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A novel influenza type A(H1N1) virus was identified as a significant cause of acute respiratory illnesses, which spread rapidly to many countries around the world in 2009. The most effective method to prevent the outbreak of influenza type A (H1N1) was performed through large-scale immunization. Research progress and adverse reaction monitoring on influenza type A (H1N1) vaccines were reviewed.</p>","PeriodicalId":56402,"journal":{"name":"中国疫苗和免疫","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29200459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Study on the compliance and economic cost of rabies vaccination]. 狂犬病疫苗接种依从性及经济成本研究
Pub Date : 2010-06-01
Chuan-lin Wang, Xiao-wei Zhang, Yong-xin Yu

Objective: To learn the compliance status regarding completing full rabies vaccination schedule, and to analyse the economic cost.

Methods: Interviewing patients who visited doctor at Emergency Department, the People's Hospital, Beijing University from June 2007 to January 2009 on vaccination compliance of Essen regimens. The economic cost of Essen regimen and Zagreb regimen were estimated using average vaccination cost, average release amount by National Institue for Control of Pharmaceutical and Biological Products.

Results: In total, 3440 patients were interviewed. The proportion completing full vaccine schedule was 33.3%, 77.1% and 78.0% for exposure category I, II and III respectively. The compliance was high for first 3 doses, it reduced significantly after the third dose. The individual medical costs was 694 RMB for Essen regimen, and 482.2 RMB for Zagreb regimen. The estimated annual medical costs was 9.709 billion RMB for Essen regimen, and 6.746 billion RMB for Zagreb regimen nationaly.

Conclusions: The Zagreb regimen should be recommended in order to simplify the vaccine administration, to increase compliance and to reduce rabies vaccination cost.

目的:了解完成狂犬病疫苗全程接种计划的情况,并分析其经济成本。方法:对2007年6月至2009年1月在北京大学人民医院急诊科就诊的患者进行埃森方案疫苗接种依从性调查。埃森方案和萨格勒布方案的经济成本采用国家药品和生物制品控制研究所的平均疫苗接种成本和平均释放量估算。结果:共访谈3440例患者。ⅰ类、ⅱ类和ⅲ类暴露者完成全部疫苗接种计划的比例分别为33.3%、77.1%和78.0%。前3次给药依从性较高,第3次给药后依从性明显降低。埃森治疗组个人医疗费用为694元,萨格勒布治疗组个人医疗费用为482.2元。埃森方案估计年医疗费用为97.09亿元,萨格勒布方案估计年医疗费用为67.46亿元。结论:为了简化疫苗管理,提高依从性,降低狂犬病疫苗接种成本,应推荐Zagreb方案。
{"title":"[Study on the compliance and economic cost of rabies vaccination].","authors":"Chuan-lin Wang,&nbsp;Xiao-wei Zhang,&nbsp;Yong-xin Yu","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To learn the compliance status regarding completing full rabies vaccination schedule, and to analyse the economic cost.</p><p><strong>Methods: </strong>Interviewing patients who visited doctor at Emergency Department, the People's Hospital, Beijing University from June 2007 to January 2009 on vaccination compliance of Essen regimens. The economic cost of Essen regimen and Zagreb regimen were estimated using average vaccination cost, average release amount by National Institue for Control of Pharmaceutical and Biological Products.</p><p><strong>Results: </strong>In total, 3440 patients were interviewed. The proportion completing full vaccine schedule was 33.3%, 77.1% and 78.0% for exposure category I, II and III respectively. The compliance was high for first 3 doses, it reduced significantly after the third dose. The individual medical costs was 694 RMB for Essen regimen, and 482.2 RMB for Zagreb regimen. The estimated annual medical costs was 9.709 billion RMB for Essen regimen, and 6.746 billion RMB for Zagreb regimen nationaly.</p><p><strong>Conclusions: </strong>The Zagreb regimen should be recommended in order to simplify the vaccine administration, to increase compliance and to reduce rabies vaccination cost.</p>","PeriodicalId":56402,"journal":{"name":"中国疫苗和免疫","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29200454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Effect analysis on non-and-low response infants after revaccinated hepatitis B vaccine]. [无反应和低反应婴儿再接种乙肝疫苗的效果分析]。
Pub Date : 2010-06-01
Zhen-hua Wu, Fu-qiang Cui, Xiao-hong Gong

Objective: To evaluate the booster immunization effect to non-and-low response children after 3 doses HepB immunization.

Methods: Non-and-low response infants born in 2004 2005 administered 3 doses of HepB at 0, 1, 6 months in Guangzhou, Beijing and Zhejiang were divided into 4 groups randomly, and boosted 3 dose of 4 different types of HepB at 0, 1, 6 months.

Results: The GMC of non-and-low response children in group A (before booster), group B (after 1 dose booster) and group C (after 3 dose booster) were 18.66 mIUml, 88.82 mIU/ml, 178.24 mIU/ml respectively; the proportion of non-responders in three groups were 20.4%, 9.1%, 1.9% respectively. In 103 non-and-low response children, proportion of titers of more than 100 mIU/ml of group B and group C were 61.2% and 84.5%, and there was statistical significant difference (chi2 = 14.13, P < 0.01). The GMC after 3 doses revaccination with four kinds of HepB, included 5 microg HepB-Y, 10 microg HepB-Y, l0 microg HepB-CHO, 10 microg HepB-HY were 168.8 mJU/ml, 174.7 mIU/ml, 184.9 mIU/ml, 182.9 mIU/ml respectively. Proportion of titers of more than 100 mIU/ml for four kinds HepB were 79.0%, 85.7%, 88.2% and 84.6% respectively, and there was no significant difference (chi2 = 0.75, 0.05).

Conclusion: There were no different of seroconversion rate between study population received 1 dose and 3 dose booster (P > 0.05), but high titer was observed after 3 dose booster. The four kinds of HepB, including 5 microg HepB-Y,10 microg HepB-Y, 10 microg HepB-CHO, 10 microg HepB-HY had the same immunization effect after 3 doses revaccination at 0, 1, 6 months to non-and-low response children.

目的:评价非应答和低应答儿童接种3次乙肝疫苗后的加强免疫效果。方法:选取2004 ~ 2005年出生的广州、北京、浙江三地的无应答和低应答婴儿,随机分为4组,分别在0、1、6月龄接种3剂HepB疫苗,分别在0、1、6月龄接种4种不同类型的HepB疫苗。结果:A组(增强前)、B组(增强1剂后)和C组(增强3剂后)无反应和低反应患儿的GMC分别为18.66 mIU/ml、88.82 mIU/ml、178.24 mIU/ml;三组无应答者比例分别为20.4%、9.1%、1.9%。103例无反应和低反应患儿中,B组和C组滴度大于100 mIU/ml的比例分别为61.2%和84.5%,差异有统计学意义(χ 2 = 14.13, P < 0.01)。5 μ g HepB- y、10 μ g HepB- y、10 μ g HepB- cho、10 μ g HepB- hy四种HepB再接种3次后的GMC分别为168.8 mJU/ml、174.7 mIU/ml、184.9 mIU/ml、182.9 mIU/ml。4种HepB抗体滴度大于100 mIU/ml的比例分别为79.0%、85.7%、88.2%和84.6%,差异无统计学意义(χ 2 = 0.75、0.05)。结论:接种1剂和3剂强化剂后血清转换率差异无统计学意义(P > 0.05),但接种3剂强化剂后血清滴度较高。在0、1、6个月对无反应和低反应儿童再接种3次后,5 μ g HepB- y、10 μ g HepB- y、10 μ g HepB- cho、10 μ g HepB- hy 4种HepB的免疫效果相同。
{"title":"[Effect analysis on non-and-low response infants after revaccinated hepatitis B vaccine].","authors":"Zhen-hua Wu,&nbsp;Fu-qiang Cui,&nbsp;Xiao-hong Gong","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the booster immunization effect to non-and-low response children after 3 doses HepB immunization.</p><p><strong>Methods: </strong>Non-and-low response infants born in 2004 2005 administered 3 doses of HepB at 0, 1, 6 months in Guangzhou, Beijing and Zhejiang were divided into 4 groups randomly, and boosted 3 dose of 4 different types of HepB at 0, 1, 6 months.</p><p><strong>Results: </strong>The GMC of non-and-low response children in group A (before booster), group B (after 1 dose booster) and group C (after 3 dose booster) were 18.66 mIUml, 88.82 mIU/ml, 178.24 mIU/ml respectively; the proportion of non-responders in three groups were 20.4%, 9.1%, 1.9% respectively. In 103 non-and-low response children, proportion of titers of more than 100 mIU/ml of group B and group C were 61.2% and 84.5%, and there was statistical significant difference (chi2 = 14.13, P < 0.01). The GMC after 3 doses revaccination with four kinds of HepB, included 5 microg HepB-Y, 10 microg HepB-Y, l0 microg HepB-CHO, 10 microg HepB-HY were 168.8 mJU/ml, 174.7 mIU/ml, 184.9 mIU/ml, 182.9 mIU/ml respectively. Proportion of titers of more than 100 mIU/ml for four kinds HepB were 79.0%, 85.7%, 88.2% and 84.6% respectively, and there was no significant difference (chi2 = 0.75, 0.05).</p><p><strong>Conclusion: </strong>There were no different of seroconversion rate between study population received 1 dose and 3 dose booster (P > 0.05), but high titer was observed after 3 dose booster. The four kinds of HepB, including 5 microg HepB-Y,10 microg HepB-Y, 10 microg HepB-CHO, 10 microg HepB-HY had the same immunization effect after 3 doses revaccination at 0, 1, 6 months to non-and-low response children.</p>","PeriodicalId":56402,"journal":{"name":"中国疫苗和免疫","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29201695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis of influenza type A(H1N1) antibody levels in different population in Gansu province]. 甘肃省不同人群甲型H1N1流感抗体水平分析
Pub Date : 2010-06-01
De-shan Yu, Hong-yu Li, Xu-ming Gao

Objective: To investigate influenza type A(H1N1) antibody levels in 3 different population which included common people, people recovered from be infected with influenza A(H1N1) and people vaccinated influenza type A(H1N1) vaccine in Gansu province in 2009.

Methods: Hemagglutination Inhibition (HI) test, HI test is positive when HI-titer > or = 1:40.

Results: The influenza type A(H1N1) antibody-positive rate of urban population were 3.64% (11/302) and 10.45% (44/421) in Gansu province in August and later November respectively. The antibody-positive rate of people vaccinated after 30 days was 46.13% (131/284), GMT was 1:21.31. 10-15 days after infected by influenza type A(H1N1), HI antibody-positive rate was 87.04%, it rose to 96.40% after 15 days vaccination, and GMT was 1:139.4.

Conclusion: In Gansu, Influenza A H1N1 outbroke firstly among students. Currently, all age groups were reported being infected with the influenza type A H1N1 virus. Only 6.65% of residents were given vaccination, antibody level of influenza type A H1N1 in people was low. Influenza type A(H1N1) virus will continue to spread in Gansu. Strengthening vaccination and improving treatment to serious cases were recommended strategies for influenza type A H1N1 control and prevention.

目的:了解2009年甘肃省普通人群、甲型H1N1流感康复者和接种甲型H1N1流感疫苗人群中甲型H1N1流感抗体水平。方法:血球凝集抑制(HI)试验,HI滴度>或= 1:40为阳性。结果:甘肃省8月和11月下旬城镇人口甲型H1N1流感抗体阳性率分别为3.64%(11/302)和10.45%(44/421)。接种30天后抗体阳性率为46.13% (131/284),GMT为1:21.31。感染甲型H1N1流感后10 ~ 15天,HI抗体阳性率为87.04%,接种15天后升至96.40%,GMT为1:13 .4。结论:甲型H1N1流感在甘肃省以学生为主。目前,据报告所有年龄组都感染了甲型H1N1流感病毒。居民甲流疫苗接种率仅为6.65%,人群甲流抗体水平较低。甲型H1N1流感病毒将继续在甘肃传播。加强疫苗接种和改善对重症病例的治疗是控制和预防甲型H1N1流感的建议策略。
{"title":"[Analysis of influenza type A(H1N1) antibody levels in different population in Gansu province].","authors":"De-shan Yu,&nbsp;Hong-yu Li,&nbsp;Xu-ming Gao","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate influenza type A(H1N1) antibody levels in 3 different population which included common people, people recovered from be infected with influenza A(H1N1) and people vaccinated influenza type A(H1N1) vaccine in Gansu province in 2009.</p><p><strong>Methods: </strong>Hemagglutination Inhibition (HI) test, HI test is positive when HI-titer > or = 1:40.</p><p><strong>Results: </strong>The influenza type A(H1N1) antibody-positive rate of urban population were 3.64% (11/302) and 10.45% (44/421) in Gansu province in August and later November respectively. The antibody-positive rate of people vaccinated after 30 days was 46.13% (131/284), GMT was 1:21.31. 10-15 days after infected by influenza type A(H1N1), HI antibody-positive rate was 87.04%, it rose to 96.40% after 15 days vaccination, and GMT was 1:139.4.</p><p><strong>Conclusion: </strong>In Gansu, Influenza A H1N1 outbroke firstly among students. Currently, all age groups were reported being infected with the influenza type A H1N1 virus. Only 6.65% of residents were given vaccination, antibody level of influenza type A H1N1 in people was low. Influenza type A(H1N1) virus will continue to spread in Gansu. Strengthening vaccination and improving treatment to serious cases were recommended strategies for influenza type A H1N1 control and prevention.</p>","PeriodicalId":56402,"journal":{"name":"中国疫苗和免疫","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29201698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis on neutralization antibody titer of Japanese B encephalitis virus in healthy population in Shaanxi province]. 陕西省健康人群乙型脑炎病毒中和抗体效价分析
Pub Date : 2010-06-01
Shao-bai Zhang, Ping Li, Xi-zhen Liu

Objective: To detect Japanese B Encephalitis virus (JEV) neutralization antibody (NA) titer and evaluate immunologic barrier, analyze the factor of affecting JEV NA titer, and provide the data for JE control.

Method: Cluster sampling was selected randomly in the region of high, middle, low JE incidence rate. To detect the NA of JEV by micro neutralization test.

Results: The positive rate of JEV NA (and GMT) was 81.3% (1:27.84) in Ankang prefecture where JE incidence rate was high, 47.9% (1:7.41) in Baoji prefecture where JE incidence rate was middle, 24.1% (1:3.04) in Tongchuan prefecture where JE disease rate was low. There was the tendency that JEV NA titer increased with increasing age in the region of high JE disease rate, and there was not this tendency in the region of low JE incidence rate.

Conclusion: In shaanxi province, the children's JEV NA titer was low in the region of high JE incidence rate, and it is important to vaccinate JE vaccine for children. The adult's JEV NA titer was low in the region of low JE incidence rate. And it is important to control JE disease in adult groups.

目的:检测乙型脑炎病毒(JEV)中和抗体(NA)滴度并评价免疫屏障,分析影响JEV NA滴度的因素,为乙脑防治提供依据。方法:在乙脑高发区、中发区、低发区随机整群抽样。采用微量中和试验检测乙脑病毒NA。结果:乙脑高发地区安康州乙脑病毒NA阳性率为81.3%(1:27.84),高发地区宝鸡州乙脑病毒NA阳性率为47.9%(1:7.41),高发地区铜川州乙脑病毒阳性率为24.1%(1:3.04)。在乙脑高发地区,乙脑病毒滴度有随年龄增加而增加的趋势,而在乙脑低发地区则无此趋势。结论:在陕西省乙脑高发地区,儿童乙脑病毒滴度较低,应加强儿童乙脑疫苗接种。乙脑低发病率地区成人乙脑病毒滴度较低。成人乙脑的控制具有重要意义。
{"title":"[Analysis on neutralization antibody titer of Japanese B encephalitis virus in healthy population in Shaanxi province].","authors":"Shao-bai Zhang,&nbsp;Ping Li,&nbsp;Xi-zhen Liu","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To detect Japanese B Encephalitis virus (JEV) neutralization antibody (NA) titer and evaluate immunologic barrier, analyze the factor of affecting JEV NA titer, and provide the data for JE control.</p><p><strong>Method: </strong>Cluster sampling was selected randomly in the region of high, middle, low JE incidence rate. To detect the NA of JEV by micro neutralization test.</p><p><strong>Results: </strong>The positive rate of JEV NA (and GMT) was 81.3% (1:27.84) in Ankang prefecture where JE incidence rate was high, 47.9% (1:7.41) in Baoji prefecture where JE incidence rate was middle, 24.1% (1:3.04) in Tongchuan prefecture where JE disease rate was low. There was the tendency that JEV NA titer increased with increasing age in the region of high JE disease rate, and there was not this tendency in the region of low JE incidence rate.</p><p><strong>Conclusion: </strong>In shaanxi province, the children's JEV NA titer was low in the region of high JE incidence rate, and it is important to vaccinate JE vaccine for children. The adult's JEV NA titer was low in the region of low JE incidence rate. And it is important to control JE disease in adult groups.</p>","PeriodicalId":56402,"journal":{"name":"中国疫苗和免疫","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29201102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis on pneumococcus isolated from part of china using serotype and pulsed-field gel electrophoresis]. [中国部分地区分离的肺炎球菌血清型及脉冲场凝胶电泳分析]。
Pub Date : 2010-06-01
Ma-chao Li, Qi Zhang, Hong-yu Ren

Objective: To investigate the serotype distribution and molecular features of Streptococcus pneumonia isolates in China.

Methods: 144 strains isolated from 6 provines were selected as the research object. The serotypes were determined with the method of capsular swelling. The molecular characteristics were conducted by optimized pulsed-field gel electrophoresis.

Results: A total of 135 Streptococcus pneumoniae isolates were divided into 14 serogroups. 19, 6, 15, 23 serogroups are prevalent types in China. 9 isolates were failed to identify specific serogroups. All isolates could be divided into 92 pulsotypes. Pulsotypes were scattered. Absolutely dominant pulsotype was not found. Pulsotypes were similar among same serogroup isolates.

Conclusion: The pneumococcus of serogroup 19, 6, 15, 23 were common in China. PFGE had strong discriminatory ability of subtyping of Streptococcus pneumoniae. PFGE showed better epidemiological survey capacity.

目的:了解中国肺炎链球菌分离株的血清型分布及分子特征。方法:选取6省144株分离株作为研究对象。采用荚膜肿胀法测定血清型。采用优化的脉冲场凝胶电泳技术对其分子特性进行了表征。结果:135株肺炎链球菌分离株分为14个血清组。19、6、15、23个血清型是中国流行型,9个分离株未发现特异性血清型。所有分离株可分为92个脉冲型。脉型分散。未发现绝对显性脉型。同一血清群分离株的脉冲型相似。结论:19、6、15、23血清群肺炎球菌在中国较为常见。PFGE对肺炎链球菌亚型有较强的区分能力。PFGE具有较好的流行病学调查能力。
{"title":"[Analysis on pneumococcus isolated from part of china using serotype and pulsed-field gel electrophoresis].","authors":"Ma-chao Li,&nbsp;Qi Zhang,&nbsp;Hong-yu Ren","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the serotype distribution and molecular features of Streptococcus pneumonia isolates in China.</p><p><strong>Methods: </strong>144 strains isolated from 6 provines were selected as the research object. The serotypes were determined with the method of capsular swelling. The molecular characteristics were conducted by optimized pulsed-field gel electrophoresis.</p><p><strong>Results: </strong>A total of 135 Streptococcus pneumoniae isolates were divided into 14 serogroups. 19, 6, 15, 23 serogroups are prevalent types in China. 9 isolates were failed to identify specific serogroups. All isolates could be divided into 92 pulsotypes. Pulsotypes were scattered. Absolutely dominant pulsotype was not found. Pulsotypes were similar among same serogroup isolates.</p><p><strong>Conclusion: </strong>The pneumococcus of serogroup 19, 6, 15, 23 were common in China. PFGE had strong discriminatory ability of subtyping of Streptococcus pneumoniae. PFGE showed better epidemiological survey capacity.</p>","PeriodicalId":56402,"journal":{"name":"中国疫苗和免疫","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29200457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中国疫苗和免疫
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1